当前位置:首页 - 行情中心 - 康美药业(600518) - 财务分析 - 现金流量表

康美药业

(600518)

  

流通市值:186.60亿  总市值:186.69亿
流通股本:138.22亿   总股本:138.29亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,543,779,811.431,100,733,187.995,487,861,781.144,001,236,403.64
  收到其他与经营活动有关的现金40,541,169.716,643,475.2495,413,442.6778,876,328.12
  经营活动现金流入小计2,584,320,981.131,117,376,663.235,583,275,223.814,080,112,731.76
  购买商品、接受劳务支付的现金1,920,556,938.52868,846,629.964,211,733,743.293,016,632,529.2
  支付给职工以及为职工支付的现金367,303,581.68195,260,163.38752,389,109.84557,655,764.08
  支付的各项税费68,886,503.8925,998,607.56155,538,840.35103,929,261.43
  支付其他与经营活动有关的现金191,521,113.5382,026,611.59352,266,902.46264,052,677.25
  经营活动现金流出小计2,548,268,137.621,172,132,012.495,471,928,595.943,942,270,231.96
  经营活动产生的现金流量净额36,052,843.51-54,755,349.26111,346,627.87137,842,499.8
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额2,632,998.792,149,941.539,788,889.3220,080,726.32
  收到的其他与投资活动有关的现金-1--
  投资活动现金流入小计2,632,998.792,149,942.539,788,889.3220,080,726.32
  购建固定资产、无形资产和其他长期资产支付的现金26,197,047.8915,701,885.89217,059,298.3874,116,991.9
  支付其他与投资活动有关的现金3,573,576.43---
  投资活动现金流出小计29,770,624.3215,701,885.89217,059,298.3874,116,991.9
  投资活动产生的现金流量净额-27,137,625.53-13,551,943.39-177,270,409.06-54,036,265.58
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,800,0001,400,000
  其中:子公司吸收少数股东投资收到的现金--1,800,0001,400,000
  取得借款收到的现金1,000,0001,000,000--
  收到其他与筹资活动有关的现金91,461,627.5841,312,265.95375,520,528.09187,093,185.99
  筹资活动现金流入小计92,461,627.5842,312,265.95377,320,528.09188,493,185.99
  偿还债务支付的现金--43,500,00043,500,000
  分配股利、利润或偿付利息支付的现金506,686.11250,000295,878.445,878.4
  其中:子公司支付给少数股东的股利、利润500,000250,000295,878.445,878.4
  支付其他与筹资活动有关的现金16,609,527.768,337,100.344,274,406.5427,282,963.24
  筹资活动现金流出小计17,116,213.878,587,100.388,070,284.9470,828,841.64
  筹资活动产生的现金流量净额75,345,413.7133,725,165.65289,250,243.15117,664,344.35
四、汇率变动对现金及现金等价物的影响-28,399.8-16,599.73-13,988.28-6,353.22
五、现金及现金等价物净增加额84,232,231.89-34,598,726.73223,312,473.68201,464,225.35
  加:期初现金及现金等价物余额1,066,292,345.451,066,292,345.45842,979,871.77842,979,871.77
  期末现金及现金等价物余额1,150,524,577.341,031,693,618.721,066,292,345.451,044,444,097.12
补充资料:
  净利润37,367,319.7-12,429,169.97-
  资产减值准备7,977,435.04-184,382,843.48-
  固定资产和投资性房地产折旧128,142,732.59-255,874,663.21-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧128,142,732.59-255,874,663.21-
  无形资产摊销8,635,944.01-21,880,963.63-
  长期待摊费用摊销11,277,884.57-21,053,236.84-
  处置固定资产、无形资产和其他长期资产的损失-3,735,062.72--846,811.6-
  固定资产报废损失302,021.81-1,464,525.08-
  公允价值变动损失-24,790.51--6,681.98-
  财务费用2,487,700.45-18,388,961.03-
  投资损失-81,612,440.05--90,603,779.48-
  递延所得税423,078.85-2,637,517.69-
  其中:递延所得税资产减少973,862.54-10,189,631.01-
    递延所得税负债增加-550,783.69--7,552,113.32-
  存货的减少-100,395,613.15-96,050,179.07-
  经营性应收项目的减少148,116,118.1--128,258,484.48-
  经营性应付项目的增加-146,109,083.86--290,337,008.43-
  现金的期末余额1,150,524,577.34-1,066,292,345.45-
  减:现金的期初余额1,066,292,345.45-842,979,871.77-
  现金及现金等价物的净增加额84,232,231.89-223,312,473.68-
公告日期2026-08-262026-04-302026-04-182025-10-31
审计意见(境内)标准无保留意见
TOP↑